Search by Drug Name or NDC

    NDC 45802-0580-84 Scopolamine Trandermal System 1 mg/1 Details

    Scopolamine Trandermal System 1 mg/1

    Scopolamine Trandermal System is a TRANSDERMAL PATCH, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is SCOPOLAMINE.

    Product Information

    NDC 45802-0580
    Product ID 45802-580_ffccef4e-1775-f875-e053-6294a90a76cc
    Associated GPIs 50200060008610
    GCN Sequence Number 004704
    GCN Sequence Number Description scopolamine PATCH TD 3 1 MG/3 DAY TRANSDERM
    HIC3 H6J
    HIC3 Description ANTIEMETIC/ANTIVERTIGO AGENTS
    GCN 18160
    HICL Sequence Number 012306
    HICL Sequence Number Description SCOPOLAMINE
    Brand/Generic Generic
    Proprietary Name Scopolamine Trandermal System
    Proprietary Name Suffix n/a
    Non-Proprietary Name scolopamine transdermal system
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form PATCH, EXTENDED RELEASE
    Route TRANSDERMAL
    Active Ingredient Strength 1
    Active Ingredient Units mg/1
    Substance Name SCOPOLAMINE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Anticholinergic [EPC], Cholinergic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078830
    Listing Certified Through 2024-12-31

    Package

    NDC 45802-0580-84 (45802058084)

    NDC Package Code 45802-580-84
    Billing NDC 45802058084
    Package 4 POUCH in 1 CARTON (45802-580-84) / 1 PATCH, EXTENDED RELEASE in 1 POUCH
    Marketing Start Date 2017-06-13
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 7.28599
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description SCOPOLAMINE 1 MG/3 DAY PATCH
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis